Anafiltamig
Product Specifications
CAS Number
3009026-69-8
Target
Others|||Immunology/Inflammation related|||Integrin
Related Pathways
Immunology/Inflammation|||Cytoskeletal Signaling|||Others
Bioactivity
Anafiltamig is a trivalent monoclonal antibody inhibitor targeting CD79B, CD3E, and MS4A1. It consists of a humanized IgG1? anti-CD79B arm and a bispecific scFv arm targeting CD3E and MS4A1. Anafiltamig can simultaneously bridge T cells and B cells, thus activating T cells to selectively kill B-cell tumors. This compound is applicable for research on B-cell malignancies, such as non-Hodgkin lymphoma.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
137979-PE 100 µL
FKTN (Fukutin, Fukuyama-type Congenital Muscular Dystrophy Protein, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4, MGC126857, MGC134944, MGC134945, MGC138243) (PE)
Ask
View Details 
GTR15210215 1 Vial
Lentiviral mouse Atg4d shRNA (UAS) - Lentiviral mouse Atg4d shRNA (UAS, RFP) (25)
Ask
View Details 035705-ML650 100 µL
FNIP2, CT (FNIP2, FNIPL, KIAA1450, MAPO1, Folliculin-interacting protein 2, FNIP1-like protein, O6-methylguanine-induced apoptosis 1 protein) (MaxLight 650) discontinued
Ask
View Details